Market News & Trends
Gerresheimer Enters Development & Production Agreement With Boehringer Ingelheim
Gerresheimer has recently been commissioned by Boehringer Ingelheim with the development and large series production of the housing module for the new generation of….
Orgenesis Announces Agreement to Acquire Koligo Therapeutics
Orgenesis Inc. and Koligo Therapeutics, Inc. recently announced the two companies have entered into a definitive merger agreement, subject to final closing conditions, with expected completion….
Mereo BioPharma Receives FDA Rare Pediatric Disease Designation
Mereo BioPharma Group plc recently announced that the US FDA has granted Rare Pediatric Disease designation to setrusumab for the treatment of osteogenesis imperfecta (OI).…
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
FSD Pharma Inc. recently announced the US FDA has authorized the initiation of a Phase 2 study for the use of FSD201 (ultramicronized palmitoylethanolamide, or…
Celyad Oncology Announces Clinical Trial Collaboration With MSD
Celyad Oncology SA recently announced it has entered into a clinical trial collaboration with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ, through…
Catalent Acquires New Biologics Facility to Create North American Clinical Manufacturing Center of Excellence
Catalent recently announced it has acquired a new manufacturing facility in Bloomington, IN, to create a North American center of excellence for early phase clinical…
Ajinomoto Bio-Pharma Services & DNDi Partner to Develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic
Ajinomoto Bio-Pharma Services recently announced a strategic supply partnership with the Drugs for Neglected Disease Initiative (DNDi), a collaborative, patients’ needs-driven, non-profit drug research and…
The IPEC Foundation Announces 2020 Award Winners
The IPEC Foundation recently announced its 2020 award winners! The winners will be recognized during the IPEC Foundation’s annual awards ceremony that will take place…
Aqualung Therapeutics Awarded NIH Fast-Track Award
Aqualung Therapeutics, an early stage biotech company developing an immune-focused, anti-inflammatory therapeutic platform for unchecked inflammation in patients with serious acute and chronic diseases, has been awarded….
Vectura Provides Status Update on Hikma's ANDA for Generic Advair Diskus VR315 (US)
Vectura Group plc, an industry-leading inhalation CDMO, recently confirmed the announcement made by its partner Hikma Pharmaceuticals PLC, which has received a minor complete response letter (CRL) from the US FDA in….
OXGENE Introduces TESSA Technology for Robust & Reproducible AAV Manufacture at Scale
OXGENE recently announced the launch of its scalable, plasmid-free manufacturing system for AAV. OXGENE’s new TESSA technology addresses….
T-knife & Catalent Sign Technology Transfer & Manufacturing Agreement
T-knife GmbH and Catalent recently announced they have signed an agreement to provide technology transfer and CGMP clinical manufacturing of T-knife’s T1367 T-cell receptor (TCR) program…..
Hovione Announces Partnership to Produce Ligand's Captisol; Used in Gilead's Covid-19 Treatment
Hovione recently announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol, a Ligand product, which is a chemically modified cyclodextrin proven to improve the solubility….
Thomas H. Lee Partners & Frazier Healthcare Partners Acquire Adare
Thomas H. Lee Partners, L.P. and Frazier Healthcare Partners recently announced they have acquired Adare Pharmaceuticals, which will be rebranded Adare Pharma Solutions, a leading specialty contract development….
TriNetX Acquired by Carlyle Group to Help Advance Health Research Optimization
TriNetX recently announced global investment firm The Carlyle Group has made a strategic growth investment and will acquire a majority stake in the company. Terms…
Metrics Contract Services Begins $10-Million Plant Expansion
Metrics Contract Services recently announced it has commenced construction on the expansion of its novel oral solid dosage manufacturing facility expansion in Greenville, NC. The…
Oculis to Present Significant Corporate & Clinical Development Progress
Oculis S.A., a biopharmaceutical company focused on developing transformative topical ophthalmic treatments to improve the sight and lives of patients, recently announced that Dr. Marcia…
Knopp Biosciences Completes Enrollment in Phase 2 Trial of Oral Dexpramipexole in Eosinophilic Asthma
Knopp Biosciences LLC recently announced the completion of enrollment in a Phase 2 trial of the oral small-molecule dexpramipexole in patients with moderate-to-severe eosinophilic asthma.…
ARCA biopharma Announces Submission of IND Application
ARCA biopharma, Inc. recently announced it has submitted an Investigational New Drug (IND) application with the US FDA under the Coronavirus Treatment Acceleration Program (CTAP) to…
Gerresheimer Announces New Laboratory & Regulatory Services for Biotech Customers
Gerresheimer recently announced it has added essential laboratory and regulatory services to its broad portfolio of products, solutions, and services for biotech companies. Specialized laboratory…
